ANNOUNCING THE HIGH PRIORITY, SHORT-TERM PROJECT AWARD (R56) 

RELEASE DATE:  June 15, 2004

NOTICE:  NOT-OD-04-047 

(NHLBI Notice of Intent to Participate in this (R56) see NOT-HL-13-188)


November 27, 2009  - See Notice NOT-NS-10-004 NINDS Notice of Intent to Participate in the High 
Priority, Short-Term Project Award (R56).

(NIDCD Notice of Intent to Participate in this (R56) see NOT-DC-09-001)

(NIDCR Intent to participate in this R56, see NOT-DE-07-002)

(NIMH now accepting R56, see NOT-MH-05-003)

National Institute of Allergy and Infectious Diseases (NIAID)
 (http://www.niaid.nih.gov)
National Cancer Institute (NCI)
 (http://www.nci.nih.gov)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
 (http://www.niaaa.nih.gov)
National Center on Complementary and Alternative Medicine (NCCAM)
 (http://www.nccam.nih.gov)
National Institute on Aging (NIA)
 (http://www.nia.nih.gov)
National Institute of Environmental Health Sciences (NIEHS)
 (http://www.niehs.nih.gov)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 (http://www.niddk.nih.gov)
National Institute on Drug Abuse (NIDA)
 (http://www.nida.nih.gov)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
 (http://www.niams.nih.gov)
National Library of Medicine (NLM)
 (http://www.nlm.nih.gov/)
National Institute of Mental Health (NIMH) (added per NOT-MH-05-003)
 (http://www.nimh.nih.gov)
National Institute of Dental and Craniofacial Research (NIDCR) (added per NOT-DE-07-002) 
(http://www.nidcr.nih.gov/)
National Institute on Deafness and Other Communication Disorders (NIDCD) (added per NOT-DE-07-002)
(http://www.nidcd.nih.gov/)
National Institute of Neurological Disorders and Stroke (NINDS) (added per NOT-NS-10-004)
(http://www.ninds.nih.gov)

 
NIH announces the new NIH High Priority, Short-Term Project Award (R56).  R56 
grants will be awarded beginning in Fiscal Year 2005. 

The new R56 grant will fund, for one or two years, high-priority new or 
competing renewal R01 applications that fall just outside the limits of 
funding of the participating NIH Institutes and Centers.  

INVESTIGATORS MAY NOT APPLY FOR AN R56 GRANT. Recipients of R56 awards will 
be selected by IC staff from R01 applications that fall at or near the 
payline margins 

Additional information is available at 
http://grants.nih.gov/grants/funding/r56.htm

DESCRIPTION

The R56 Award will provide limited, interim research support based on the 
merit of a pending application.  The R56 will enable an applicant to gather 
additional data for revision of a new or competing renewal application. R56 
funding will end after one or two years or when the applicant succeeds in 
obtaining traditional project funding.  The High Priority, Short-Term Project 
Awards will underwrite highly meritorious applications with funds that can 
range up to initial review group recommended levels.

The R56 award will help early career stage scientists trying to establish 
research careers as well as more experienced scientists who just miss getting 
funded.  The R56 will provide interim funding while they revise their 
applications.  

FEATURES

A.  The R56 grant will be available to domestic R01 applicants only.

B. Investigators may not apply for an R56 grant. 

C.  Competing R01 applications prepared and submitted in accordance with NIH 
procedures will be peer reviewed and assigned a priority score and in most 
cases a percentile rating.  Nominees for the R56 will come from the R01 
applications pending for the current fiscal year. Nominees for the award must 
be in the most meritorious half of the priority or percentile range.  
Previously approved, but inactivated, applications from this time period may 
be considered and if awarded will be converted to an R56.

D. The awards may be funded up to the IRG recommended and Council approved 
levels and indirect costs will be provided at the negotiated rate.  

E. R56 awardees will be encouraged to submit a revision of their original 
competing application at the earliest convenient date to be considered for 
future funding.  Applicants are reminded that the limitations and the 
number of amendments described at 
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-041.html 
apply to all subsequent revisions.  

F. If a revised competing application is funded while an R56 award is active, 
the balance of the R56 Award will be deducted from the approved amount of the 
competing award.

G. A final progress report, final financial status report, and final 
invention statement (HHS 568) will be required 90 days after the end of the 
R56 grant period.  The progress report must identify those portions of the 
original proposal pursued with the R56 Award.  If the awardee is successful 
with a subsequent application, the progress report in the revised application 
will suffice as a progress report for the R56 Award and a final invention 
statement will not be required.

REVIEW CRITERIA AND PROCEDURES

NIH staff, initial review groups, and the institute and Center Advisory 
Councils and Boards will review R01 applications in the usual manner.  
Program administrators will identify and nominate applications near the 
payline for conversion to an R56.  Awards will be selected based on the 
scientifically creative and innovative approaches that meet the mission of 
the Institute or Center.

INQUIRIES

For information concerning the new R56 Award, contact:  
 
PARTICIPATING NIH INSTITUTES 

National Institute of Allergy and Infectious Diseases (NIAID)
Allan Czarra 
Deputy Director, DEA, NIAID, NIH, DHHS 
Room 2140 
6700-B Rockledge Drive - MSC 7610 
Bethesda, MD  20892-7610 
For express deliveries, use ZIP code 20817-7610 
Phone:  (301) 496-7291 
FAX: (301) 402-0369 
E-mail:  aczarra@niaid.nih.gov 
Website: http://www.niaid.nih.gov 

National Cancer Institute (NCI)
Christopher L. Hatch, Ph.D.
Chief, Program Coordination and Referral Branch
Division of Extramural Activities 
National Cancer Institute 
6116 Executive Blvd., Room 8047
Bethesda, MD 20892-8329
Rockville, MD 20852 (for express/courier delivery)
Phone: 301-594-1403
Fax: 301-402-0275
Email: hatchc@mail.nih.gov
Website: http://www.nci.nih.gov 

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Kenneth R. Warren, Ph.D.
Director, Office of Scientific Affairs
5635 Fishers Lane
Bethesda, MD  20892-1705
Phone: 301-443-5494
Fax: 301-443-7043
Email: kwarren@mail.nih.gov
Website: http://www.niaaa.nih.gov

National Center on Complementary and Alternative Medicine (NCCAM)
Richard L. Nahin, Ph.D., MPH
Senior Advisor for Scientific Coordination and Outreach
National Center for Complementary and Alternative Medicine
9000 Rockville Pike
Bldg. 31, Rm. 2B11
MSC 2182
Bethesda, MD 20892-2182
phone:  301-496-7801
fax:  301-435-6549
email:  nahinr@mail.nih.gov
Website: http://www.nccam.nih.gov

National Institute on Aging (NIA)
Dr. Miriam F. Kelty, Ph.D
Associate Director, Extramural Activities
7201 Wisconsin Ave, Room 2C218, MSC 2292
Bethesda, MD 20892
Phone: 301-496-9322
Fax: 301-402-2945
Email: mk46u@nih.gov
Website: http://www.nia.nih.gov

National Institute of Environmental Health Sciences (NIEHS)
Anne P. Sassaman
Director, Division of Extramural Research and Training
National Institute of Environmental Health Sciences
National Institutes of Health
P.O. Box 12233
Research Triangle Park, NC. 27709
Phone:  (919) 541-7723
Fax:    (919) 541-2843
Email:  sassaman@niehs.nih.gov
Website: http://www.niehs.nih.gov 

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Joyce A. Hunter, Ph.D.
Deputy Director
Division of Extramural Activities
National Institute of Diabetes and Digestive and Kidney Diseases
Two Democracy Plaza, Room 714
6707 Democracy Boulevard
Bethesda, MD  20892-5456
Phone: (301) 594-0056
Fax: (301) 480-4125
Email: jh602o@nih.gov
Website: http://www.niddk.nih.gov

National Institute on Drug Abuse (NIDA)
Teresa Levitin, Ph.D.
Director, Office of Extramural Affairs
6101 Executive Blvd, Room 220 MSC 8401
Bethesda, MD 20892-8401
Phone:  301 443-2755
Fax: 303 443-0538
Email: TL25u@nih.gov
Website: http://www.nida.nih.gov 

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Cheryl A. Kitt, Ph.D.
Director, Extramural Program
National Institute of Arthritis and Musculoskeletal and Skin Diseases
NIH, DHHS
One Democracy Plaza
6701 Democracy Blvd., Room 804
Bethesda, MD  20892-4872
Tel: 301-594-2463
Fax: 301-480-4543
Email: kittc@mail.nih.gov
Website: http://www.niams.nih.gov

National Library of Medicine (NLM)
Valerie Florance, Ph.D. 
Deputy Director, Division of Extramural Programs
Rockledge 1, Suite 301,
6705 Rockledge Drive 
Bethesda, MD 20892 
Phone: (301) 594-4882
Fax (301) 402-2952
Email: floranv@mail.nih.gov 
Website: http://www.nlm.nih.gov/ep


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices



NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®



Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.